Fresenius Medical Care AG & Co. KGaA ADR represents shares of the global healthcare company specializing in dialysis treatments and related products. The primary function of Fresenius Medical Care is to provide comprehensive care for patients suffering from chronic kidney failure. This includes offering dialysis services and manufacturing essential components such as dialysis machines, dialysis fluids, and related disposables. The company's product and service range is integral to healthcare systems worldwide, impacting hospitals, outpatient dialysis centers, and home care setups. As an American Depository Receipt (ADR), this asset allows investors in the United States stock market to invest in Fresenius Medical Care, which is primarily listed in Germany. This facilitates investment in one of the leading companies in the nephrology sector, providing exposure to the essential healthcare market that continues to expand due to increasing prevalence of chronic diseases globally.
Earnings calendar coming soon. Subscribe to get notified when FMS reports next.
Get earnings alerts →